1H-Indole-6-carboxamide, N-((1R)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxo-1-phenylethyl)-
LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).